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The strength of titanium scaffolds with the introduction of high porosity decreases dramatically and may
become inadequate for load bearing in biomedical applications. To simultaneously meet the re-
quirements of biocompatibility, low elastic modulus and appropriate strength for orthopedic implant
materials, it is highly desirable to develop new biocompatible titanium based materials with enhanced
strength. In this study, we developed a niobium pentoxide (Nb2O5) reinforced titanium composite via
powder metallurgy for biomedical applications. The strength of the Nb2O5 reinforced titanium com-
posites (Ti-Nb2O5) is signiﬁcantly higher than that of pure titanium. Cell culture results revealed that the
Ti-Nb2O5 composite exhibits excellent biocompatibility and cell adhesion. Human osteoblast-like cells
grew and spread healthily on the surface of the Ti-Nb2O5 composite. Our study demonstrated that Nb2O5
reinforced titanium composite is a promising implant material by virtue of its high mechanical strength
and excellent biocompatibility.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of KeAi Communications Co., Ltd.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).1. Introduction
Titanium (Ti) has shown the greatest potential to be thematerial
basis of load-bearing implant applications due to its excellent
mechanical strength, biocompatibility over alternative bio-
materials, such as polymers and ceramics [1,2]. It also possesses a
relatively low elastic modulus and excellent corrosion resistance
compared with other metal biomaterials, such as SUS316L stainless
steel and CoeCreMo alloys. However, pure titanium used today is
in its solid forms and often much stiffer than human bone as the
elastic modulus of titanium implants is much higher than that of
natural bone [1,2]. This mismatch of elastic modulus causes stress
shielding, leading to implant loosening and eventual failure [1,3].
The elastic modulus of titanium can be tailored through the
introduction of a porous structure [4,5]. A porous structure may
also provide new bone tissue ingrowth ability and vascularization,
which make porous titanium as a promising scaffold biomaterial
for bone tissue engineering. However, the strength of porous tita-
nium decreases dramatically with the introduction of porosity, andnications Co., Ltd.
ing by Elsevier B.V. on behalf of Ke
d/4.0/).becomes lower than that of natural bone when with high porosity
[3,5]. To be a successful implant, it is necessary to simultaneously
meet the requirements of low elastic modulus, appropriate
strength and excellent biocompatibility for load-bearing implant
materials.
Particulate-reinforced metal matrix composites (MMCs) are
known to provide a higher strength and hardness, and better wear
resistance, compared to unreinforced metals [6e8]. The appro-
priate selection of reinforcement and metal matrix systems are of
critical importance for ensuring a property combination of
biocompatibility, high strength and high wear resistance. Volume
fraction, shape, size, and orientation of the reinforcement phase in
metal matrix play an essential role in determining the properties of
MMCs. A wide range of metal systems and reinforcements are
available for MMCs, including, for example, Al, Mg, Ni, Ti, Cu, Fe,
etc., and reinforcement systems in the form of whiskers, ﬁbers, and
particulates, for instance, boron, carbon ﬁber, carbon nanotubes,
Kevlar, silicon carbide and various metal oxides. Particulate-
reinforced metal matrix composites have attracted extensive
attention as a result of their relatively low costs and characteristic
isotropic properties.8 Silicon carbide, boron carbide, titanium car-
bide, titanium diboride, zirconium diboride, and aluminum oxide
are commonly used to produce reinforced titanium composites [9].
However, for particulate-reinforced MMCs for biomaterialsAi Communications Co., Ltd. This is an open access article under the CC BY-NC-ND
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properties but also excellent biocompatibility. Silicon carbide, bo-
ron carbide, titanium diboride, zirconium diboride, and aluminum
oxide may be of insufﬁcient biocompatibility according to their
Material Safety Data Sheets [10]. To ensure the particulate-
reinforced MMCs with excellent biocompatibility, the selected
particle reinforcements should be biocompatible [11e13].
Niobium pentoxide (Nb2O5) is considered biocompatible [10].
The titanium alloy coated with Nb2O5 by using a solegel technique
can signiﬁcantly improve its biocompatibility, bioactivity and
corrosion resistance [14,15]. It has been reported that particulate-
reinforced titanium metal matrix composites using metal oxides
as reinforcements, such as TiO2, SiO2, ZrO2 and SrO, show promising
mechanical properties and excellent biocompatibility for orthope-
dic implant materials [16e18]. In this study, to simultaneously
achieve high strength and excellent biocompatibility for load-
bearing applications, we attempt reinforcing titanium metal ma-
trix with Nb2O5 particulate to fabricate a Ti-Nb2O5 composite for
biomedical applications. The mechanical properties and the
microstructure of the particulate-reinforced Ti-Nb2O5 composite
were evaluated using compression tests and scanning electron
microscopy (SEM). The in vitro biocompatibility and cell adhesion
behavior of the Ti-Nb2O5 composite were assessed by using human
osteoblast-like SaOS2 cells.2. Experimental methods
Processing methods for MMCs play a crucial role in the prop-
erties of the ﬁnal titanium-metal oxide composites. Powder met-
allurgy has several advantages in the processing of metal matrix
composites since it can synthesize a wider range of compositions
with relatively low costs and characteristic isotropic properties
[3,5]. Typical powder metallurgy process to fabricate MMCs is
schematically shown in Fig. 1.
In this study, titanium powder (purity of 99.8%, average particle
size ~ 45 mm, Atlantic Equipment Engineers, USA), and Nb2O5 par-
ticles (purity of 99.9%, average particle size < 45 mm, Sigma-Aldrich,
Australia) were used as the starting materials. The morphologies of
the starting materials are shown in Fig. 2. Powder mixtures for the
niobium pentoxide reinforced titanium composites containing 2%,
3%, and 4% of Nb2O5 (weight percent, hereafter) were blended in a
planetary ball mill for 2 h at a weight ratio (balls to powder) of 10:1
and a rotation speed of 100 rpm. The mixtures of titanium powder
and Nb2O5 particles were consolidated using a cold presser at
300 MPa and then sintered at 1000 C in a vacuum furnace at 106
torr to obtain the MMCs. Titanium composite disc samples with a
diameter of 9 mm and thickness of 2 mm were cut from theFig. 1. Schematic illustration of powder metallurgy process in the fabrsintered products for microstructure characterization, phase anal-
ysis, and in vitro biocompatibility assessments. Cylinder composite
samples with a diameter of 3 mm and a height of 6 mmwere used
for evaluating the mechanical properties under compression.
Compressive tests were performed at room temperature at an
initial strain rate of 103 s1 using an Instron universal tester
equipped with a video extensometer (Instron 5567, Norwood, MA).
Characterization of the microstructures of the Ti-Nb2O5 composites
was performed by scanning electron microscopy (Quanta 200,
USA).
Osteoblast-like cells (SaOS2, a human osteosarcoma cell line
with osteoblastic properties, Barwon Biomedical Research, Geelong
Hospital, Victoria, Australia) were used to assess the in vitro
biocompatibility of the Ti-Nb2O5 composites based on a direct
contact method [3,11]. SaOS2 cells were cultured in a modiﬁed
minimum essential medium (MMEM) at 37 C in a humidiﬁed at-
mosphere of 5% CO2 in air. MMEM composed of minimum essential
medium (MEM, Gibco, Invitrogen, Mulgrave, VIC, Australia), 10%
fetal bovine serum (Bovogen Biologicals, Essendon, Victoria,
Australia), 1% non-essential amino acid (Sigma-Aldrich, Castle Hill,
NSW, Australia), 10,000 units/mL penicillin-10,000 mg/mL strepto-
mycin (Gibco), and 0.4% amphostat B (In Vitro Technologies,
Auckland, New Zealand). The culture mediumwas changed every 3
days. When cells become conﬂuent, they were harvested by using
0.1% Trypsin-5 mM EDTA (Sigma-Aldrich, Australia) and collected
for use.
For the in vitro assessment, all samples were sterilized in an
autoclave. The samples were then placed in a 48-well cell culture
plate with each well containing one sample covered with 200 ml
MMEM. SaOS2 cells were seeded at a density of 5  103 cells per
well. After incubating the cells in a humidiﬁed atmosphere with 5%
CO2 in air at 37 C for 7 d, MTS assay was performed to measure the
cell number in the wells. The respective medium in each well was
replaced by 150 ml phenol red free MEM. MTS/PMS solution of 50 ml
was added in each well and the cell culture plate was incubated for
1 h at 37 C in a humidiﬁed atmosphere of 5% CO2 in air. Then,100 ml
from each well was transferred to a 96-well plate for absorbance
reading at 490 nm using a spectrophotometer (GENios Pro, Tecan,
Mannedorf, Switzerland).
The cell morphology of the osteoblast-like cells (SaOS2) on the
surfaces of the Ti-Nb2O5 composite samples was observed using a
confocal microscope (Leica SP45, Germany) and scan electron mi-
croscopy (SEM). For confocal microscopy observation, the cell-
seeded discs after cell culture were ﬁxed in 2% paraformaldehyde
and permeabilised with 0.2% (v/v) triton-X100 in phosphate-
buffered saline (PBS) (Sigma-Aldrich, Australia) each for 10 min at
room temperature. The discs were then incubated with 1%ication of particulate reinforced metal matrix composites (MMCs).
Fig. 2. Morphologies of starting materials: (a) Ti powder and (b) Nb2O5 powder.
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4 C. Three washes by PBS were included in between each of the
steps mentioned above. The stained samples were stored in PBS
until required and confocal microscopy observations of these
samples were conducted within a week of staining. For SEM
observation, the cell-seeded discs after cell culture were ﬁxed in
3.9% glutaraldehyde for 1 h at room temperature. Then the cells
were dehydrated through sequential washings in 60, 70, 80, 90, 95,
and 100% ethanol solutions for 10 min each. After that, the samples
were chemically dried using hexamethyldisilazane (HMDS) and
coated with gold for SEM observation.
All cell culture experiments were conducted in triplicates. Re-
sults were expressed as mean ± standard deviation (SD). One-way
ANOVA (SPSS 14.0 for windows) was applied to determine the
statistical signiﬁcance of the differences observed between groups.
p < 0.05 was considered as statistically signiﬁcant. The optical
density (OD) values for all samples were converted to the respective
viable cell counts using a standard curve and a cell viability ratio
(CVR) for every sample was calculated using the following
equation:
CVR ¼ ðViable cell count in sampleÞ=
ðViable cell count in controlÞ (1)
3. Results and discussion
Fig. 3 shows the X-ray diffraction patterns of the Ti-Nb2O5Fig. 3. XRD patterns of Ti-Nb2O5 composites witcomposites with different Nb2O5 contents. The Ti-Nb2O5 compos-
ites showed mainly the sharp peaks attributable to a-Ti. The peak
intensities of the reinforcing phase Nb2O5 increased with
increasing of Nb2O5 addition to the composites. It can been seen
that there was no new phase formed after the vacuum sintering of
the Ti-Nb2O5 powder mixtures.
Fig. 4 shows the microstructure of Ti-Nb2O5 composites with
different Nb2O5 additions and EDX analysis of Ti/4% Nb2O5 com-
posite. It can be seen from Fig. 4(a) e (c) that the average grain size
did not change signiﬁcantly with the increasing of Nb2O5 addition
from 2% to 4%. The porosity of the Ti-Nb2O5 composites was 4%, 3%
and 2% for the composite with the Nb2O5 addition of 2%, 3% and 4%,
respectively. The porosity difference for the composites with
different percentage of particulate reinforcement can be considered
negligible. Fig. 4(d) and (e) show the EDX spectra of the spots of the
matrix and around a Nb2O5 particle which indicate the composi-
tions. The boundary of the pore displays rich Nb contents and the
grain matrix contains very low Nb content. It suggests that the
Nb2O5 particles (Fig. 4 (a)e(c)) were almost removed during the
grinding and polishing processes, leaving behind the pores.
The mechanical properties of the Ti-Nb2O5 composites are
shown in Fig. 5. It can be seen that the compressive yield strengths
of the titanium matrix composites with 2%, 3% and 4% of Nb2O5
additions are 1245 ± 52,1310 ± 54 and 1409 ± 58MPa, respectively,
which are higher than that of pure titanium fabricated by powder
metallurgy (1046 ± 50MPa) [16]. The compressive yield strength of
the Ti-Nb2O5 composites increased with increasing Nb2O5 addition.
However, the ultimate strains of the Ti-Nb2O5 composites were
lower than that of pure titanium, which indicate that the additionh (a) 0, (b) 2%, (c) 3%, and (d) 4% of Nb2O5.
Fig. 4. Microstructure of Ti-Nb2O5 composite with: (a) 2%, (b) 3%, and (c) 4% of Nb2O5; (d) EDX spectrum indicating the composition of “y” as marked in the matrix in (c); (e) EDX
spectrum indicating the composition of “z” as marked in the boundary of the pore in (c).
Fig. 5. Mechanical properties of the Ti-Nb2O5 composites.
Fig. 6. Cell adhesion and variability of osteoblast-like SaOS2 cells on the Ti-Nb2O5
composites after cell culture for 7 d.
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posites. Also, the ultimate strains of the Ti/Nb2O5 composites
decreased with increasing Nb2O5 addition. The Ti-Nb2O5 compos-
ites with 2, 3, and 4% of Nb2O5 addition showed an ultimate strain
of 22 ± 2, 15 ± 1.9 and 13 ± 1.5%, respectively.
The biocompatibility of an implant material plays an important
role in ensuring a successful implantation. To assess the biocom-
patibility and cell response of the Ti-Nb2O5 composites, in vitro
assessments were carried out using human osteoblast-like SaOS2
cells. Fig. 6 shows the cell proliferation and variability of osteoblast-
like SaOS2 cells on the composite disc samples after cell culture for
7 d. It can be seen that all the Ti-Nb2O5 composites exhibited a
similar or comparable cell proliferation and variability compared to
pure titanium,which indicated that the Ti-Nb2O5 composites in this
study are nontoxic and of excellent biocompatibility.
As Ti/4%Nb2O5 composite contained the highest content of
Nb2O5, the investigation of cell adhesion morphology on its surface
was carried out through the confocal microscopy and SEM. The
confocal micrographs of SaOS2 cells on the surface of the Ti/4%
Nb2O5 composite after cell culture for 1 and 7 d are shown in Fig. 7.
The insert in Fig. 7(b) shows the SEM image of the cell morphol-
ogies after culturing for 7 d. It can be seen that the SaOS2 cellsattached, spread, and grew healthily on the surfaces of the Ti/4%
Nb2O5 composite. At the early stage of cell culture for 1 d (Fig. 7(a)),
it can be seen that only limited numbers of SaOS2 cells attached to
Ti/4%Nb2O5 composite surface; however, after culturing for 7 d, the
cell numbers increased substantially. It is also noticeable that there
were cells spreading with extracellular matrix on Ti/4%Nb2O5
composite surface (Fig. 7(b)), which indicated the Ti/4%Nb2O5
composite possesses excellent biocompatibility. The result of cell
morphology and attachment observation is consistent with that of
MTS assay.
4. Conclusions
This study investigated the microstructure, the mechanical
properties and the biocompatibility of particulate-reinforced Ti-
Nb2O5 composites (MMCs) fabricated via powder metallurgy. The
strength of the MMCs is signiﬁcantly higher than that of pure ti-
tanium. Cell culture assessment revealed that the MMCs exhibit
excellent biocompatibility. Human osteoblast-like SaOS2 cells grow
and spread healthily on the surfaces of the MMCs. This study
Fig. 7. Cell morphologies of osteoblast-like SaOS2 cells on the Ti/4%Nb2O5 composite after cell culture for: (a) 1 d and (b) 7 d.
Y. Li et al. / Bioactive Materials 1 (2016) 127e131 131illustrated the feasibility of using the particulate-reinforced Ti-
Nb2O5 composites as orthopedic implant materials.
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